Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

July 14, 2016

Primary Completion Date

April 19, 2023

Study Completion Date

April 19, 2023

Conditions
Ovarian Cancer
Interventions
PROCEDURE

Hyperthermic intraperitoneal chemotherapy (HIPEC)

Hyperthermic intraperitoneal chemotherapy (HIPEC) is a procedure in which the internal parts of the abdomen are bathed in a warm solution of anti-cancer medications for 90 minutes.

DRUG

Carboplatin

"Carboplatin, delivered as HIPEC, will be administered at the time of surgery. Subjects will receive a single cycle of hyperthermic intraperitoneal chemotherapy.~a single dose of carboplatin (800 mg/m2) will be administered in normal saline via intraperitoneal hyperthermic perfusion using the closed-abdomen technique. HIPEC will be continued for 90 minutes in the hyperthermic phase (41°C-43°C)."

Trial Locations (1)

92354

Women's Cancer and Surgical Oncology Center, Loma Linda

All Listed Sponsors
lead

Loma Linda University

OTHER

NCT02672098 - Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer | Biotech Hunter | Biotech Hunter